AxoGen Announces the Inauguration of Its Social Media Platforms

ALACHUA, Fla.--(BUSINESS WIRE)-- AxoGen has launched the first of its social media platforms: @AxoGen on Twitter. Eventually, they plan to expand their social media marketing with other platforms like Facebook®, YouTube®, and Linkedin®. Karen Zaderej, CEO of AxoGen, Inc., states, “We are excited to provide an additional forum to reach out to surgeons and share business updates, technical data and case reports. Social media will also provide us with a way to connect with patients suffering from peripheral nerve injuries. I see social media playing an instrumental role in our communication efforts.”

AxoGen is bringing the science of nerve repair to life by working with leading researchers to develop innovative products to treat peripheral nerve damage. AxoGen has developed an innovative technology platform making it possible to process allograft nerves while preserving the relevant characteristics of the three dimensional scaffold of the nerve tissue. Avance® Nerve Graft is the first commercially available allograft nerve for bridging nerve discontinuities. The AxoGuard® product line provides nerve protection and facilitates connection of damaged nerves using an innovative material that supports repair with revascularization and remodeling. AxoGen, Inc. is a privately held company based in Alachua, Florida, AxoGen has received funding from private investors including Accuitive Medical Ventures, Cardinal Partners, De Novo Ventures, JAM Capital and Springboard Capital II, LLC.

AxoGen is a registered tissue establishment with the FDA.

Visit AxoGen at:

Follow @AxoGen on Twitter!


AxoGen Incorporated
Monica L. Tarver, +1 386-462-6834
[email protected]

KEYWORDS:   United States  North America  Florida

INDUSTRY KEYWORDS:   Health  Biotechnology  Hospitals  Medical Devices  Other Health